Current Environment: Production

Suzanna Hirsch | Education

Undergraduate School

Wesleyan University

Middletown, CT

Medical School

Albert Einstein College of Medicine

Bronx, NY

Residency

Boston Combined Residency Program (BCRP)

2018, Boston, MA

Fellowship

Boston Children's Hospital

2021, Boston, MA

Suzanna Hirsch | Certifications

  • American Board of Pediatrics (Gastroenterology)
  • American Board of Pediatrics (General)

Suzanna Hirsch | Professional History

Dr. Hirsch is a pediatric gastroenterologist whose practice focuses on the evaluation and treatment of aerodigestive disorders in children. She has a particular interest in treating children with refractory upper gastrointestinal symptoms, such as feeding intolerance, vomiting, and gastroesophageal reflux. Her research is aimed at better defining the pathophysiology underlying these challenging symptoms, with the goal of using this improved mechanistic knowledge to advance current treatments and guide new treatment innovations. She has received funding from the National Institutes of Health and the American Neurogastroenterology and Motility Society (ANMS) to support this work.
 

Suzanna Hirsch | Publications

  1. Ten-Year Trends in Pharmacologic Management of Gastroesophageal Reflux Disease and Pediatric Feeding Disorders in Young Children. J Pediatr. 2025 Apr 27; 283:114628. View Ten-Year Trends in Pharmacologic Management of Gastroesophageal Reflux Disease and Pediatric Feeding Disorders in Young Children. Abstract

  2. Proton Pump Inhibitors and Risk of COVID-19 Infection in Children. J Pediatr. 2024 Nov; 274:114179. View Proton Pump Inhibitors and Risk of COVID-19 Infection in Children. Abstract

  3. The Real Relevance of Nonacid Reflux in Pediatric Patients. J Clin Gastroenterol. 2023 09 01; 57(8):754-759. View The Real Relevance of Nonacid Reflux in Pediatric Patients. Abstract

  4. Characterization of Eosinophilic Esophagitis in Infants and Toddlers. J Pediatr Gastroenterol Nutr. 2023 07 01; 77(1):86-92. View Characterization of Eosinophilic Esophagitis in Infants and Toddlers. Abstract

  5. Author response to letter to the editor. Neurogastroenterol Motil. 2022 Dec; 34(12):e14478. View Author response to letter to the editor. Abstract

  6. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting. Neurogastroenterol Motil. 2022 Nov; 34(11):e14428. View A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting. Abstract

  7. Effect of Added Free Water to Enteral Tube Feeds in Children Receiving Commercial Blends. J Pediatr Gastroenterol Nutr. 2022 03 01; 74(3):419-423. View Effect of Added Free Water to Enteral Tube Feeds in Children Receiving Commercial Blends. Abstract

  8. Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children. Paediatr Drugs. 2022 Jan; 24(1):73-81. View Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children. Abstract

  9. Comparison of Aerodigestive and Nonaerodigestive Provider Responses to Clinical Case Vignettes. J Pediatr. 2021 05; 232:166-175.e2. View Comparison of Aerodigestive and Nonaerodigestive Provider Responses to Clinical Case Vignettes. Abstract

  10. Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children. J Pediatr. 2020 11; 226:228-235. View Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children. Abstract

  11. Eye-tracking, autonomic, and electrophysiological correlates of emotional face processing in adolescents with autism spectrum disorder. J Autism Dev Disord. 2013 Jan; 43(1):188-99. View Eye-tracking, autonomic, and electrophysiological correlates of emotional face processing in adolescents with autism spectrum disorder. Abstract

  12. Atypical face processing in children with tuberous sclerosis complex. J Child Neurol. 2013 Dec; 28(12):1569-76. View Atypical face processing in children with tuberous sclerosis complex. Abstract

BESbswy